Goldman Sachs Group Inc Sqz Biotechnologies CO Transaction History

Goldman Sachs Group Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 14, 2024	BUY	$0.27 - $0.68 $273 - $688	1,012 Added 6.8%	15,896 $4,000
Q2 2023 Aug 14, 2023	BUY	$0.27 - $0.68 $273 - $688	1,012 Added 6.8%	15,896 $4,000
Q1 2023 May 14, 2024	SELL	$0.53 - $0.87 $1,757 - $2,884	-3,316 Reduced 18.22%	14,884 $8,000
Q1 2023 May 11, 2023	SELL	$0.53 - $0.87 $1,757 - $2,884	-3,316 Reduced 18.22%	14,884 $8,000
Q4 2022 May 14, 2024	SELL	$0.67 - $2.85 $5,088 - $21,645	-7,595 Reduced 29.44%	18,200 $13,000
Q4 2022 Feb 13, 2023	SELL	$0.67 - $2.85 $5,088 - $21,645	-7,595 Reduced 29.44%	18,200 $13,000
Q3 2022 May 14, 2024	SELL	$2.16 - $3.48 $48,018 - $77,363	-22,231 Reduced 46.29%	25,795 $58,000
Q3 2022 Nov 10, 2022	SELL	$2.16 - $3.48 $48,018 - $77,363	-22,231 Reduced 46.29%	25,795 $0
Q2 2022 May 14, 2024	BUY	$2.77 - $5.0 $133,032 - $240,130	48,026 New	48,026 $152,000
Q2 2022 Aug 15, 2022	BUY	$2.77 - $5.0 $51,616 - $93,170	18,634 Added 63.4%	48,026 $152,000
Q1 2022 May 16, 2022	SELL	$4.01 - $10.42 $56,328 - $146,369	-14,047 Reduced 32.34%	29,392 $141,000
Q4 2021 Feb 14, 2022	BUY	$8.93 - $14.85 $75,449 - $125,467	8,449 Added 24.15%	43,439 $388,000
Q3 2021 Nov 10, 2021	BUY	$11.46 - $15.77 $400,985 - $551,792	34,990 New	34,990 $505,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.